The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
ACR 2012 Highlights: Osteoarthritis and Physical Activity
November 29th 2012Presentations at the American College of Rheumatology meeting last month revealed yet more robust evidence of the tight correlation between physical activity (or lack of it) and osteoarthritis. Different studies show that this relationship begins in childhood and extends throughout the lifespan.
Mounting Evidence Casts Uric Acid as Central Player in Cardiovascular Disease
November 28th 2012Beyond causing gout, uric acid appears to be on the verge of stepping into a far broader role. Collectively, numerous clinical and animal studies portray it as the central villain in the mystery that links hypertension, kidney failure, and diabetes.
Missed Lung Disease in Community-Treated Systemic JIA Often Fatal
November 21st 2012Many doctors appear not to be recognizing or treating pulmonary hypertension and interstitial lung disease among patients with systemic juvenile idiopathic arthritis, according to a study using an electronic listserv of patients.
Excess Weight Linked to Increased Risk of Developing Rheumatoid Arthritis
Overweight women face a higher risk of rheumatoid arthritis than their normal-weight peers, according to a study presented at the annual scientific meeting of the American College of Rheumatology in Washington, DC.
Rheumatic Drug Safety Updates 2012: FDA at the ACR Meeting
November 14th 2012New label changes about hepatic risks with the gout drug febuxostat (Uloric) and uncertainties about the new oral RA drug tofacitinib (Xeljanz) were on the agenda as the most important new drug issues arising this year, as FDA officials spoke at the American College of Rheumatology meeting.
Study Shows Methotrexate and Prednisone Combination Therapy Achieves Remission for Most RA Patients
Results presented at the American College of Rheumatology/Association of Rheumatology Professionals 2012 annual meeting show that adalimumab and methotrexate are more effective than DMARDs and prednisone in achieving remission in patients with early rheumatoid arthritis or undifferentiated arthritis patients.
Briefer Two-Drug Regimen Offers Dramatic Results in Lupus Case Series
November 12th 2012Doctors at New York's Hospital for Special Surgery have added rituximab and reduced the number of cycles of cyclophosphamide in lupus treatments, leading many patients to forgo steroids and wonder whether they still have the disease.
The Importance of Ultrasound in Choosing RA Treatment
November 12th 2012(VIDEO) Ultrasound can trump the DAS28 in judging the equation between rheumatoid arthritis symptoms and joint signs when making treatment decisions. James Dale MD describes his study reported at the American College of Rheumatology meeting.
ACR Panel Issues Evidence-Based Recommendations for Ultrasound
November 3rd 2012Relatively inexpensive, safe, and effective, musculoskeletal ultrasound has been widely accepted in rheumatology without evidence for its benefits. A review panel for the American College of Rheumatology has issued evidence-based recommendations, which will be discussed in detail next week at its annual conference in Washington DC.